American Healthcare REIT, Inc. (AHR) Investment Analysis

1. Executive Summary:

American Healthcare REIT, Inc. (NYSE: AHR) stands as a preeminent, self-managed real estate investment trust specializing in the acquisition and management of clinical healthcare real estate. The company maintains a strategic focus on assets that provide essential medical services, primarily within the senior housing, skilled nursing, and outpatient medical sectors. With a diversified portfolio that extends across the United States, the United Kingdom, and the Isle of Man, the entity has positioned itself to capitalize on the profound demographic shifts associated with an aging global population. The company’s operational philosophy is centered on the integration of real estate ownership with clinical service delivery, a model that differentiates it from more traditional, "lifestyle-oriented" senior housing providers.

The revenue generation of American Healthcare REIT is categorized into four distinct reporting segments: Integrated Senior Health Campuses (ISHC), Senior Housing Operating Properties (SHOP), Outpatient Medical buildings, and Triple-Net Leased (NNN) properties. The ISHC segment, which features the company’s significant investment in Trilogy Health Services, serves as a cornerstone of the portfolio. These campuses provide a full continuum of care, ranging from independent living to high-acuity skilled nursing and rehabilitative services. By offering multiple levels of care on a single campus, the company achieves higher resident retention and clinical flexibility, which in turn drives superior occupancy and revenue stability.

In the SHOP segment, the company utilizes the RIDEA (REIT Investment Trust Act of 2007) structure, which allows the REIT to participate directly in the operating cash flows of its properties while engaging third-party managers to oversee day-to-day operations. This structure is particularly advantageous in periods of rising occupancy and rent growth, as the REIT captures the full upside of operational improvements. The Outpatient Medical segment focuses on medical office buildings (MOBs) and specialty hubs that cater to the increasing migration of healthcare services from inpatient hospitals to lower-cost outpatient settings. Finally, the Triple-Net Leased segment consists of properties leased to third-party operators under long-term agreements where the tenant is responsible for nearly all property-related expenses, providing a stable and predictable layer of rental income.

The company’s primary customers include aging seniors requiring various levels of health and social support, as well as healthcare providers and health systems that lease outpatient medical space. As of the third quarter of 2025, the company reported total consolidated revenue of $572.9 million, reflecting a robust growth trajectory fueled by both organic same-store performance and an aggressive external acquisition program. The entity’s strategic focus on "needs-based" healthcare real estate ensures a durable demand profile that is largely insulated from discretionary consumer spending cycles.

2. Business Drivers & Strategic Overview:

The primary revenue drivers for American Healthcare REIT are rooted in the widening supply-demand imbalance within the senior housing and healthcare sectors. The "Silver Tsunami"—the rapid growth of the population aged 80 and older—is the fundamental macroeconomic force driving long-term demand for the company’s assets. This demographic group is the primary consumer of high-acuity senior housing and skilled nursing services. Simultaneously, the supply of new units has remained historically constrained due to elevated construction costs, high interest rates, and regulatory hurdles. This environment has bestowed significant pricing power upon owners of existing high-quality assets.

Growth Initiatives and Portfolio Optimization

External growth through strategic acquisitions is a critical component of the company's expansion strategy. Throughout 2025, American Healthcare REIT completed over $950 million in new acquisitions, primarily targeting high-growth ISHC and SHOP assets. These transactions included a 14-property portfolio of long-term care assets acquired in December 2025, which added over 1,400 beds to the ISHC segment. The company’s ability to execute large-scale acquisitions even in a volatile interest rate environment is a testament to its disciplined capital allocation and its "just-in-time" equity raising via at-the-market (ATM) programs.

The company also engages in "capital recycling," a process of selling non-core or older assets to fund the acquisition of modern, high-acuity facilities. In 2025, the company sold multiple non-core properties, redeploying the proceeds into assets with higher growth potential and lower anticipated capital expenditure requirements. This strategy not only improves the overall quality of the portfolio but also accelerates growth in Normalized Funds from Operations (NFFO) as the new assets stabilize.

Competitive Advantages and Operational Moats

The most significant competitive advantage for American Healthcare REIT is its integrated campus model, particularly through the Trilogy JV. Unlike competitors that may only offer assisted living or skilled nursing as standalone products, the ISHC segment provides a "continuum of care". This model allows the company to capture residents earlier in their healthcare journey and retain them as their acuity levels increase. Furthermore, the clinical focus of the portfolio makes it an essential partner for health systems looking to manage post-acute patient outcomes effectively.

The company’s decentralized management approach also serves as a differentiator. By partnering with highly curated, trusted regional operating partners like Heritage Senior Living and Great Lakes Management, the REIT ensures that its properties are managed by teams with deep local market expertise. This allows for more nimble operational adjustments in response to local labor trends and competitive pressures, which is essential in a service-intensive industry like healthcare.

Market Position and Share Dynamics

American Healthcare REIT has emerged as a high-growth alternative to the industry’s "Big Three" healthcare REITs. Since its successful listing in early 2024, the company has consistently outperformed peers like Welltower and Ventas in terms of same-store NOI growth and price appreciation. Its inclusion in the S&P MidCap 400 in February 2026 marked a pivotal milestone, signaling to institutional investors that the entity has reached a level of scale and liquidity comparable to its more established peers. The company is currently "winning" market share by aggressively expanding its operating portfolio while larger peers are focused on de-leveraging or refining their legacy portfolios.

3. Financial Performance & Valuation:

The financial performance of American Healthcare REIT in 2025 was characterized by record-setting growth and a significant strengthening of the balance sheet. The company’s operational metrics, particularly in its ISHC and SHOP segments, have consistently exceeded historical norms for the sector.

Recent Historical Performance (2025)

For the third quarter of 2025, the company reported NFFO of $0.44 per diluted share, surpassing consensus estimates by a significant margin. Total consolidated revenue reached $572.9 million, representing a 5.6% increase over the prior quarter and a massive year-over-year jump. The primary engine of this growth was the operating portfolio, which achieved total portfolio same-store NOI growth of 16.4%.

The entity’s full-year 2025 NFFO guidance was raised to a range of $1.69 to $1.72 per share, representing approximately 20% growth over the previous year. This upward revision was driven by sustained high occupancy in the SHOP segment—which reached a spot occupancy of 90%—and disciplined expense management that mitigated the impact of labor inflation.

Valuation Multiples and Peer Comparison

As of February 2026, American Healthcare REIT trades at a valuation that reflects its high-growth status while remaining attractively priced relative to its larger-cap peers.

While AHR's Price/NFFO multiple has expanded significantly since its IPO, the multiple remains justifiable given its superior NOI growth rates compared to the "Big Three" healthcare REITs. Analysts have estimated that the REIT’s intrinsic value may be as high as $56 to $57 per share, suggesting that the current market price of $51.80 still provides some margin for appreciation as the company’s massive 2025 acquisition pipeline begins to contribute fully to the bottom line.

Capital Structure and Liquidity

The company’s capital structure has undergone a significant transformation. As of the third quarter of 2025, the Net Debt-to-Annualized Adjusted EBITDA improved to 3.5x, down from 5.1x just a year prior. This deleveraging was achieved through disciplined equity issuance and the settlement of forward sales agreements, which provided approximately $127.8 million in gross proceeds in Q3 alone. The company maintains robust liquidity of nearly $1 billion, providing it with the dry powder necessary to continue its opportunistic acquisition strategy.

4. Risk Assessment & Macroeconomic Considerations:

Despite its strong operational momentum, American Healthcare REIT is subject to several risks that could impact its 5-year trajectory. These risks are a combination of idiosyncratic management issues, operational challenges within the healthcare sector, and broader macroeconomic volatility.

Leadership Transition and Key Person Risk

A significant near-term risk surfaced in February 2026 with the announcement that CEO Danny Prosky would take a medical leave of absence. While the board’s appointment of Chairman Jeffrey T. Hanson—who previously led the company as CEO for six years—provides stability, the sudden absence of the primary architect of the company’s recent growth strategy introduces leadership uncertainty. Any prolonged absence or permanent change in leadership could affect the execution of the company’s $450 million investment pipeline and its relationships with key operating partners.

Labor Inflation and Operational Margin Compression

The healthcare and senior housing sectors are inherently labor-intensive. While the company has been successful in managing expenses, any resurgence in wage inflation or a shortage of qualified nursing staff could lead to a spike in the use of expensive "agency labor". Because the ISHC and SHOP segments are operating businesses, the REIT is directly exposed to these cost fluctuations. While rent growth has been able to outpace inflation thus far, there is a ceiling to the "pricing power" that residents can absorb before occupancy begins to suffer.

Macroeconomic and Interest Rate Sensitivity

As a capital-intensive business, American Healthcare REIT is highly sensitive to the interest rate environment. Although rates began to moderate in late 2025, a reversal or a "higher-for-longer" scenario could increase the cost of debt and lead to cap rate expansion. If cap rates for healthcare real estate expand, the Net Asset Value (NAV) of the company’s properties would decline, potentially impacting the share price. Furthermore, the entity’s reliance on the equity markets for funding means that a sustained market downturn could restrict its ability to raise the capital needed for its acquisition-led growth strategy.

Regulatory and Reimbursement Risks

While a large portion of the portfolio is private-pay, the skilled nursing components of the Integrated Senior Health Campuses (ISHC) have exposure to government reimbursement through Medicare and Medicaid. Changes in federal or state budgets, or shifts in regulatory requirements for staffing ratios, could increase operating costs or decrease the profitability of these clinical settings. The company’s geographic concentration in the UK also exposes it to different regulatory regimes and currency risks, although these currently represent a smaller portion of total revenue.

5. 5-Year Scenario Analysis:

The following scenario analysis projects the potential total return for American Healthcare REIT (AHR) over a 5-year period (2026–2030). These "guesstimates" are based on the company's current financial trajectory, analyst consensus, and the macroeconomic outlook for the healthcare real estate sector. The starting share price is $51.80.

Base Case: Disciplined Expansion

The Base Case assumes that the company continues to execute its strategy of steady, accretive acquisitions while maintaining its current operational excellence.

• Key Fundamentals:

  • Sales Growth: 6.5% CAGR, driven by 4% organic rent/rate growth and $500M in annual acquisitions.

  • NFFO Growth: 7.5% CAGR. NFFO grows from $1.71 (2025E) to $2.46 in 2030.

  • Occupancy: SHOP occupancy stabilizes at 91.5%, benefiting from the supply-demand imbalance.

  • Capital Allocation: Maintains a 60% dividend payout ratio; the annual dividend grows to $1.48 by 2030.

  • Valuation: Terminal Price/NFFO of 22x, reflecting a more mature but still healthy REIT profile.

• Projected Share Price (2030): $54.12

• Total Return (5-year): ~17% (Inclusive of cumulative dividends)

High Case: M&A Powerhouse

The High Case assumes the company maintains its 2025 acquisition pace of ~$1B per year and successfully integrates several large-scale portfolios at high yields.

• Key Fundamentals:

  • Sales Growth: 11.5% CAGR. Aggressive growth in both the ISHC and SHOP segments through market consolidation.

  • NFFO Growth: 13% CAGR. NFFO reaches $3.15 by 2030, driven by significant operating leverage and cap rate compression.

  • Occupancy: Total portfolio occupancy reaches 93.5% as new supply remains non-existent.

  • Valuation: Terminal Price/NFFO of 26x. Investors award AHR a premium multiple consistent with the sector’s top-tier performers.

• Projected Share Price (2030): $81.90

• Total Return (5-year): ~71% (Inclusive of aggressive dividend growth)

Low Case: Stagnation and Margin Pressure

The Low Case assumes that labor inflation remains persistent and government reimbursement cuts impact the ISHC segment, while high interest rates stall the acquisition market.

• Key Fundamentals:

  • Sales Growth: 2% CAGR. Acquisitions stop entirely due to a high cost of capital; same-store growth is offset by resident move-outs to lower-cost settings.

  • NFFO Growth: 1.5% CAGR. NFFO reaches $1.84 by 2030, barely keeping pace with maintenance capital expenditures.

  • Occupancy: Drops to 84% as the "choice-based" portion of the SHOP segment is impacted by a weak economy.

  • Valuation: Terminal Price/NFFO of 14x. The market de-rates the stock due to its higher operational risk profile.

• Projected Share Price (2030): $25.76

• Total Return (5-year): -38% (Inclusive of a stagnant $1.00 annual dividend)

Scenario Summary Table

Probability Weighted Outcome

The probability-weighted price target of $55.42 suggests that the stock is currently trading near a fair valuation, with a moderate upside potential of approximately 7% before considering dividend distributions. The high case provides significant "blue sky" potential if the company can maintain its current growth velocity, while the low case highlights the risks of its operational exposure.

DEMOGRAPHIC GROWTH ENGINE

6. Qualitative Scorecard:

Management Alignment: 8/10

The company’s management is deeply experienced and heavily invested in the success of the REIT. Jeffrey Hanson and Danny Prosky have been instrumental in the company’s evolution from a non-traded entity to a NYSE-listed leader. Insiders own roughly 1% of the shares, which, while seemingly small, represents a significant personal commitment for a $9 billion entity. The 2025 Manager Equity Plan further aligns executive compensation with shareholder returns, though recent insider sales by the Chairman and EVP are worth monitoring for sentiment shifts.

Revenue Quality: 7/10

Revenue quality is strong but has a higher risk-reward profile than traditional healthcare REITs. The ISHC and SHOP segments provide "high-octane" growth during upswings but expose the company to operational risks like labor and clinical liability. The Outpatient Medical segment provides a high-quality, stable anchor to the portfolio with long-term leases and high-credit tenants.

Market Position: 9/10

American Healthcare REIT is clearly "winning" market share. Its inclusion in the S&P MidCap 400 and its ability to outpace the big-cap healthcare REITs in same-store NOI growth confirm its rising status. The company is capturing the "sweet spot" of the mid-market regional operating space, which is often overlooked by the industry giants.

Growth Outlook: 9/10

The growth outlook remains exceptionally positive due to the demographic tailwinds and the supply contraction in senior housing. With a pipeline of awarded deals exceeding $450 million and a demonstrated ability to raise capital, the entity is well-positioned to maintain its external growth trajectory through the end of the decade.

Financial Health: 8/10

The company’s financial health is excellent. A Net Debt-to-EBITDA ratio of 3.5x is conservative for the sector and provides substantial flexibility. The liquidity position of nearly $1 billion and the lack of significant near-term debt maturities ensure that the REIT can weather temporary market disruptions.

Business Viability: 8/10

The durability of the business is high, as the services provided are medically necessary and needs-based. The aging of the population is a biological certainty, ensuring a growing customer base for decades. Potential choke points include the availability of healthcare labor, but the company's regional operator model is designed to mitigate this risk through local scale.

Capital Allocation: 9/10

Management has demonstrated superior capital allocation skills. The use of ATM programs to raise equity and the strategic recycling of assets have consistently resulted in FFO-accretive outcomes. The decision to buy back joint venture interests in Trilogy at attractive valuations is a notable example of opportunistic value creation.

Analyst Sentiment: 9/10

Analyst sentiment is overwhelmingly positive, with the majority of Wall Street firms maintaining "Buy" or "Strong Buy" ratings. Recent price target increases to the $55-$60 range reflect growing confidence in the entity’s ability to sustain its 2025 growth levels into 2026.

Profitability: 6/10

While NFFO growth is high, GAAP profitability remains modest due to the significant depreciation and amortization typical of the REIT sector. The entity’s return on equity is currently low but is expected to expand as the massive 2025 acquisition investments begin to mature and stabilize.

Track Record: 8/10

Since listing, the company has established a strong track record of meeting or exceeding financial guidance. The successful transition from a private to a public platform while simultaneously deleveraging and growing is a significant achievement.

BLENDED SCORE: 8.1 / 10

INSTITUTIONAL GRADE OPERATOR

7. Conclusion & Investment Thesis:

The investment thesis for American Healthcare REIT is predicated on the convergence of favorable demographics and disciplined operational execution. The company is currently in the "sweet spot" of its growth cycle, having reached sufficient scale to access institutional capital while remaining small enough for individual acquisitions to move the needle on FFO per share. The company's strategic focus on integrated campuses and high-acuity clinical real estate provides a defensive moat, as these services are less susceptible to economic downturns than independent living or lifestyle-focused senior housing.

Key catalysts for the next 12 months include the potential return of CEO Danny Prosky, the stabilization of the 2025 acquisition portfolio, and the continued migration of medical procedures to outpatient settings. While the share price has appreciated significantly, the entity’s valuation remains reasonable compared to its growth rate, suggesting that it remains attractively valued for long-term investors. The main risks—labor inflation and interest rate volatility—are sector-wide challenges that the entity is well-positioned to manage due to its low leverage and high-quality operator partnerships. In summary, American Healthcare REIT represents a core holding for those seeking exposure to the aging demographic trend through a disciplined, high-growth platform.

SCALABLE HEALTHCARE PLATFORM

8. Technical Analysis, Price Action & Short-Term Outlook:

American Healthcare REIT (AHR) is currently in a strong technical uptrend, trading at $51.80, which is significantly above its 200-day moving average of $45.40 and its 50-day moving average of $47.97. The stock recently hit a new 52-week high, driven by its inclusion in the S&P MidCap 400 and positive analyst commentary. Short-term indicators such as the RSI and MACD suggest a "Strong Buy" outlook, though some "overbought" signals indicate potential for brief consolidation near the $52 resistance level. The short-term outlook is positive, with investors awaiting the Q4 2025 earnings report on February 26, 2026, for further confirmation of the growth trajectory.

BULLISH TECHNICAL MOMENTUM